The largest purchase of all time was on 2020-03-13 and amounted to 12674270 shares of Kala Pharmaceuticals, Inc. for $100M.
The largest sale of all time was on 2022-05-23 and amounted to 1250000 shares of Kala Pharmaceuticals, Inc. for $812,500.
No biography is available at this moment.
| 2022-08-03 | AN2 Therapeutics, Inc. ANTX | 1,809 0.0271% | $7.48 | $13,531 | +16% | |||
| 2022-07-26 | AN2 Therapeutics, Inc. ANTX | 8,281 0.1313% | $7.91 | $65,503 | +21.76% | |||
| 2022-07-01 | 89bio, Inc. ETNB | 2.82M 6.5316% | $3.55 | $10M | +239.97% | |||
| 2022-06-21 | AN2 Therapeutics, Inc. ANTX | 302 0.0048% | $7.99 | $2,413 | +18.35% | |||
| 2022-06-13 | AN2 Therapeutics, Inc. ANTX | 20,000 0.3166% | $7.90 | $158,000 | +25.06% | |||
| 2022-05-26 | Sale | Kala Pharmaceuticals, Inc. KALA | 1.01M 1.4295% | $0.36 | $365,667 | -10.55% | ||
| 2022-05-23 | Sale | Kala Pharmaceuticals, Inc. KALA | 1.25M 1.8204% | $0.65 | $812,500 | -48.51% | ||
| 2022-05-10 | PepGen Inc. PEPG | 249,749 1.9076% | $12.00 | $3M | +7.35% | |||
| 2022-03-29 | AN2 Therapeutics, Inc. ANTX | 115,613 3.4755% | $15.00 | $1.73M | -24.72% | |||
| 2022-03-14 | Cytek Biosciences, Inc. CTKB | 241,727 0.1819% | $12.27 | $2.96M | -4.77% | |||
| 2022-03-09 | Cytek Biosciences, Inc. CTKB | 337,492 0.247% | $12.77 | $4.31M | -10.59% | |||
| 2022-03-04 | Cytek Biosciences, Inc. CTKB | 63,662 0.0459% | $12.99 | $827,230 | -12.74% | |||
| 2020-03-13 | Kala Pharmaceuticals, Inc. KALA | 12.67M 37.859% | $7.89 | $100M | +33.64% | |||
| 2020-02-03 | Black Diamond Therapeutics, Inc. BDTX | director | 2M 4.2195% | $19.00 | $38M | -15.11% | ||
| 2018-10-03 | Kala Pharmaceuticals, Inc. KALA | 4.85M 15.3518% | $8.25 | $40M | -22.45% | |||
| 2018-01-30 | Solid Biosciences Inc. SLDB | director | 1M 2.4225% | $16.00 | $16M | +33.16% | ||
| 2017-10-12 | KalVista Pharmaceuticals, Inc. KALV | 1.7M 15.9429% | $8.50 | $14.45M | +10.54% | |||
| 2017-07-25 | Kala Pharmaceuticals, Inc. KALA | director | 1.07M 4.6208% | $15.00 | $16M | -13.88% |